Publication | Closed Access

Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells

Hematological MalignancyCell Cycle ProgressionCdk InhibitorMedicineMalignant Blood DisorderPharmacologyAnti-cancer AgentCancer TreatmentOncologyCell BiologyCancer Research